BSE Live
Dec 26, 09:02Prev. Close
5563.80
Open Price
0.00
Bid Price (Qty.)
5563.80 (5)
Offer Price (Qty.)
5646.00 (5)
NSE Live
Dec 26, 09:06Prev. Close
5566.00
Open Price
5533.00
Bid Price (Qty.)
5566.00 (3)
Offer Price (Qty.)
5350.00 (1)
| Cash Flow of Alkem Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,527.03 | 2,023.13 | 1,304.77 | 1,844.28 | 1,842.10 | |
| Net CashFlow From Operating Activities | 1,912.84 | 1,948.07 | 1,682.50 | 1,111.02 | 1,264.90 | |
| Net Cash Used In Investing Activities | -1,298.76 | -1,008.50 | 112.84 | -1,435.13 | -998.54 | |
| Net Cash Used From Financing Activities | -810.99 | -1,145.01 | -1,760.82 | 379.57 | -271.75 | |
| Foreign Exchange Gains / Losses | 10.51 | -2.05 | 7.10 | 2.50 | 3.67 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -186.40 | -207.49 | 41.62 | 57.96 | -1.72 | |
| Cash And Cash Equivalents Begin of Year | 66.31 | 273.80 | 232.18 | 174.22 | 175.94 | |
| Cash And Cash Equivalents End Of Year | -120.09 | 66.31 | 273.80 | 232.18 | 174.22 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key